HBsAg seroconversion with pegylated interferon treatment for chronic hepatitis B
Feruze Yılmaz Enç, Canan YeşiloğluGöztepe Training and Research Hospital, Gastroenterology, IstanbulEach year HBsAg seroconversion appears spontenously between the range of 1-2 percent and also antiHBs appears in 1/3 of these cases. HBsAg seroconversion is % 4 for the treatment with convensional interferon and this rate is also similar for the treatment with pegylated interferon. Here we present a patient with chronic hepatitis B who treated with pegylated interferon, had seroconversion of HBsAg.
Keywords: Chronic hepatit B, treatment with peginterferon, anti HBs apperanceKronik hepatit B’de peginterferon tedavisi
Feruze Yılmaz Enç, Canan YeşiloğluGöztepe Eğitim Araştırma Hastanesi, Gastroenteroloji Kliniği, İstanbulAnahtar Kelimeler: Kronik hepatit B, peginterferon tedavisi, anti HBs pozitifleşmesi
Feruze Yılmaz Enç, Canan Yeşiloğlu. HBsAg seroconversion with pegylated interferon treatment for chronic hepatitis B. . 2007; 22(4): 156-157
Corresponding Author: Feruze Yılmaz Enç, Türkiye
Corresponding Author: Feruze Yılmaz Enç, Türkiye
| TOOLS |
 Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author
Similar articles Google Scholar |